ESC CVD Risk Calculation
source

ESC CVD Risk Calculation

(15)
Price
Free
Category
Medical
Last update
May 05, 2021
Publisher
European Society of Cardiology Contact publisher
Loading...

Ratings & Reviews performance

Ratings & Reviews performance provides an overview of what users think of your app. Here are the key metrics to help you identify how your app is rated by users and how successful is your review management strategy.

Number of reviews,
total
15
Avg rating,
total
⭐4.5
Loading...

Description

1259 chars

The ESC CVD Risk Calculation App is designed for healthcare professionals. It provides calculators assessing individual cardiovascular risk and provides insights on the effect of treatment. It includes calculators for primary and secondary prevention in various populations: SCORE ASCVD ADVANCE ELDERLY SMART SMART-REACH* DIAL* LIFE-CVD* * Available online on U-Prevent (Internet connection required) The ESC CVD Risk Calculation App is available in English. It provides guidance to the most adapted calculator for your patient, and provides an estimation of cardiovascular risk and related treatment effect. Of note, patient data are not stored in the App. This application is only for informative use and is not intended to provide therapeutic support or diagnosis assistance. It is developed by the European Society of Cardiology (ESC), based upon the U-Prevent webtool developed and owned by University Medical Center Utrecht. The Application has been developed for the ESC Prevention of Cardiovascular Disease Programme, which is supported by Amgen, AstraZeneca, Ferrer, Sanofi and Regeneron in the form of educational grants. The sponsors did not have any involvement or influence in the features nor the scientific content of the Application.

Screenshots

https://play-lh.googleusercontent.com/B0dS0oBU34cQLzeJeNEy2ps-aTg5no5iCV9BfmI3gFSJTHhKKRP2Qj6Cz8s5jzdzF4w=w720-h310https://play-lh.googleusercontent.com/1QAv2jJc1lpzSwXBrKV2CHJttuQ8RG5VQ89dDI4DCCe2aWNoogbUyBaW4k6iUPTHuec=w720-h310https://play-lh.googleusercontent.com/BRFegDJfkCIk0RsIUmCpPYufsSkuRxH6XnuTAnhMjtfNMsV2M52wuS6G74NIrb4cw1Y=w720-h310https://play-lh.googleusercontent.com/Eoq29BF7HRhUUcRW6GwAAK7Y4RDyxcFygN_iwSux2zHMXfkZ9T6H_se7Vg_uDJbDiA=w720-h310https://play-lh.googleusercontent.com/LREVlNk83Ts33NWPQCRlikOGrgQdijJeHF5eQN5gqboFSOy16tlKSdmfjLOtfCivqw=w720-h310https://play-lh.googleusercontent.com/DjuI_EMiu2XR10aZEzP6AQ9Rku7l7j2a37luS5omyv84GIQAC3Sdq99mjEANqg3NrCM=w720-h310https://play-lh.googleusercontent.com/4waONyNvEm3ID3-Q_1PsBDafIvko-t7CX9RvGbY9lbMhldZZ2-RMxiY9xwec7CLyLA=w720-h310https://play-lh.googleusercontent.com/oVHlNs6KGt49LBwtEYCZFbK0fW8QEAMxkgXzwYtSPdoex5bDRWC93ZfTYyaOxexIt2g=w720-h310
Loading...
Loading...

Find growth insights on our blog

React to user feedback and market trends faster